Faculty profile

René Gaudreault

Back to faculty

ProfessorDépartement de médecine moléculaireUniversité Laval

René Gaudreault

Professor

Département de médecine moléculaire

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
14 publications in the last five years, latest in 2026.
Senior (last) author on 8 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

105

Publications

2,203

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Université Laval profile.

Latest papers

FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938.
Pharmaceuticals (Basel, Switzerland) · 2026
Toxicity, Half-Life and Antitumor Activity of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as Novel Antimitotic CYP1A1-Targeted Prodrugs in Female Mouse Models.
Pharmaceutics · 2025
Synthesis and evaluation of the biological properties of boron-containing and boron-omitted capsaicin derivatives on human cancer cell lines
Results in Chemistry · 2024

All 105 publications

105 publications.

FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938.

Bruxelles Q, Hamel-Côté G, Scott-Boyer MP, Ouellette V, C-Gaudreault R, Durocher F, Diorio C, Droit A, Fortin S

Pharmaceuticals (Basel, Switzerland)20261 citationsOpen Access

DOI: 10.3390/ph19030357 PMID: 41901204

Toxicity, Half-Life and Antitumor Activity of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as Novel Antimitotic CYP1A1-Targeted Prodrugs in Female Mouse Models.

Chavez Alvarez AC, Bouzriba C, Ouellette V, Gagné-Boulet M, Patenaude A, Pilote S, C-Gaudreault R, Simard C, Fortin S

Pharmaceutics20251 citationsOpen Access

DOI: 10.3390/pharmaceutics17020233 PMID: 40006600

Synthesis and evaluation of the biological properties of boron-containing and boron-omitted capsaicin derivatives on human cancer cell lines

Anne-Sophie Carpentier, Luis Misal, Sharwatie Ramsaywack, Christopher M. Vogels, Stéphane Gobeil, Stephen A. Westcott, Rene C. Gaudreault, Frédéric‐Georges Fontaine

Results in Chemistry20242 citationsOpen Access

DOI: 10.1016/j.rechem.2024.101493

Development of an UHPLC-UV Method for Quantification of Three Phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates in CD-1® IGS Female Mouse Plasma

Atziri Corin Chavez Alvarez, Chahrazed Bouzriba, Laureline Bernier, Vincent Ouellette, Mathieu Gagné‐Boulet, Sylvie Pilote, Rene C. Gaudreault, Chantale Simard, Sébastien Fortin

Journal of Analytical Chemistry20241 citations

DOI: 10.1134/s1061934824040026

Homologation of the Alkyl Side Chain of Antimitotic Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonate Prodrugs Selectively Targeting CYP1A1-Expressing Breast Cancers Improves Their Stability in Rodent Liver Microsomes.

Chavez Alvarez AC, Bouzriba C, Moreau E, Auzeloux P, Besse S, Ouellette V, Zarifi Khosroshahi M, Côté MF, Pilote S, Miot-Noirault E, Chezal JM, Simard C, C-Gaudreault R, Fortin S

Journal of medicinal chemistry20238 citationsOpen Access

DOI: 10.1021/acs.jmedchem.2c01268 PMID: 36780426

Data from New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia

Alexandre Patenaude, Réna G. Deschesnes, Jean L.C. Rousseau, Éric Petitclerc, Jacques Lacroix, Marie‐France Côté, Rene C. Gaudreault

2023Senior authorOpen Access

DOI: 10.1158/0008-5472.c.6496454.v1

Supplementary Figure 3 from New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia

Alexandre Patenaude, Réna G. Deschesnes, Jean L.C. Rousseau, Éric Petitclerc, Jacques Lacroix, Marie‐France Côté, Rene C. Gaudreault

2023Senior authorOpen Access

DOI: 10.1158/0008-5472.22370597

Synthesis and Evaluation of the Biological Properties of Novel Boron-Containing Capsaicin Derivatives on Human Cancer Cell Lines

Alain Carpentier, Luis Misal, Sharwatie Ramsaywack, Christopher M. Vogels, Stéphane Gobeil, Stephen A. Westcott, Rene C. Gaudreault, Frédéric‐Georges Fontaine

SSRN Electronic Journal2023Open Access

DOI: 10.2139/ssrn.4640455

Data from New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia

Alexandre Patenaude, Réna G. Deschesnes, Jean L.C. Rousseau, Éric Petitclerc, Jacques Lacroix, Marie‐France Côté, Rene C. Gaudreault

2023Senior authorOpen Access

DOI: 10.1158/0008-5472.c.6496454

Supplementary Figure 3 from New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia

Alexandre Patenaude, Réna G. Deschesnes, Jean L.C. Rousseau, Éric Petitclerc, Jacques Lacroix, Marie‐France Côté, Rene C. Gaudreault

2023Senior authorOpen Access

DOI: 10.1158/0008-5472.22370597.v1

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

René Gaudreault

Research

Latest papers

FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938.

Toxicity, Half-Life and Antitumor Activity of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as Novel Antimitotic CYP1A1-Targeted Prodrugs in Female Mouse Models.

Synthesis and evaluation of the biological properties of boron-containing and boron-omitted capsaicin derivatives on human cancer cell lines

Development of an UHPLC-UV Method for Quantification of Three Phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates in CD-1® IGS Female Mouse Plasma

Homologation of the Alkyl Side Chain of Antimitotic Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonate Prodrugs Selectively Targeting CYP1A1-Expressing Breast Cancers Improves Their Stability in Rodent Liver Microsomes.

Data from New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia

Supplementary Figure 3 from New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia

Synthesis and Evaluation of the Biological Properties of Novel Boron-Containing Capsaicin Derivatives on Human Cancer Cell Lines

Data from New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia

Supplementary Figure 3 from New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia

Frequent collaborators

René C.-Gaudreault

Sébastien Fortin

Jacques Lacroix

François Marceau

Lakshmi Kotra

Jean Legault

Gaétan Laroche

Chantale Simard

Michel Desjardins

Luc Bernier

Marc-André Fortin

Jean-Claude Forest

Francine Durocher

Caroline Diorio

Frédéric-Georges Fontaine

Jean-François Paquin

Stephen Westcott

Chris Vogels

Patrick Mathieu

Diego Mantovani